Real-world results with IgPro20 for hypo- or agammaglobulinemia in Japan
{{output}}
Background: Subcutaneous immunoglobulin is one of the standard treatments for hypogammaglobulinemia in primary immunodeficiencies (PID) worldwide. In Japan, IgPro20 (Hizentra® ; l-proline-stabilized 20% human subcutaneous immuno... ...
